These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6114575)

  • 1. [Importance of obsidan for increasing exercise tolerance in elderly patients with ischemic heart disease].
    Kotko DN; Fed'ko GP; Iaroshenko IuT
    Ter Arkh; 1980; 52(8):22-5. PubMed ID: 6114575
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol)].
    Adamska-Dyniewska H
    Wiad Lek; 1973 Jul; 26(13):1201-5. PubMed ID: 4147032
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta-adrenoblockaders and calcium antagonists in the treatment of patients with ischemic heart disease combined with hypertension].
    Andrushchenko EV; Chmir VP; Krasovskaia EA; Malanchuk TA; Polishchuk II; Iashchenko OB
    Vrach Delo; 1990 Nov; (11):35-8. PubMed ID: 1983050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ischaemic heart disease with beta-adrenoblocking agents Trimepranol and Obsidan.
    Gasilin VS; Grigoriants RA; Lupanov VP; Lobova NM
    Cor Vasa; 1983; 25(1):10-6. PubMed ID: 6133699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of anapriline on the thyroid function and lipid metabolism in ischemic heart disease in elderly patients].
    Gorbachev VV; Pristrom MS
    Ter Arkh; 1983; 55(5):53-6. PubMed ID: 6137075
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coronary and left ventricular dynamics of three substances with different beta-blocking effects: Propranolol, Pindolol, and Practolol].
    Moccetti T; Halter J; Lichtlen P
    Schweiz Med Wochenschr; 1972 Mar; 102(12):422-5. PubMed ID: 4401753
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of different groups of adrenergic beta receptor blockaders on the clinical course of the disease, work capacity and echocardiographic indicators in ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Bragina GI
    Ter Arkh; 1979; 51(8):13-7. PubMed ID: 41333
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of a one-time dose of prolonged-action beta-adrenoblockaders and nitrates on the tolerance of physical loads in ischemic heart disease].
    Ermilov LP; Kuleshova EV; Treshkur TV; Andreeva IV
    Klin Med (Mosk); 1980 Apr; 58(4):77-81. PubMed ID: 6103973
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sympathetic-adrenal system in ischemic heart disease before and after obzidan treatment].
    Orlov VN; Chigrinova LS
    Klin Med (Mosk); 1981 Jun; 59(6):74-8. PubMed ID: 6116820
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined effects of propranolol and trapidil on ischemic heart disease--exercise tolerance and cardiac function].
    Ito T; Su K; Sada T; Amano N; Naito A; Oka Y; Okabe F; Sekine I; Matsumoto S
    Kokyu To Junkan; 1983 May; 31(5):541-7. PubMed ID: 6635363
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
    Wlazłowski R; Kruszyński G; Goch JH
    Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of propranolol on left ventricular function at rest and during exercise in patients with ischemic heart disease (author's transl)].
    Jebavý P; Ressl J; Jandová R
    Cas Lek Cesk; 1974 Feb; 113(7):199-205. PubMed ID: 4434438
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease.
    Winniford MD; Hillis LD
    Herz; 1982 Aug; 7(4):243-9. PubMed ID: 6127300
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of -adrenergic blocking and non-specific properties of propranolol.
    Coltart DJ
    Br Heart J; 1971 Jul; 33(4):615. PubMed ID: 4397633
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of beta adrenergic blockaders on the effort test in coronary insufficiency].
    Demiroglu C; Oztürk M
    Presse Med (1893); 1971 Apr; 79(17):765-6. PubMed ID: 4396515
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of anaprilin on the contractile and pump functions of the left ventricle in elderly patients with chronic ischemic heart disease].
    Ivanov IA
    Vrach Delo; 1984 Feb; (2):40-3. PubMed ID: 6719868
    [No Abstract]   [Full Text] [Related]  

  • 17. [The efficacy of proxodolol, a new beta-adrenoblockader with alpha-adrenoblockader properties, in its single use in patients with stable stenocardia of effort].
    Metelitsa VI; Martsevich SIu; Kozyreva MP; Slastnikova ID; Vakulovskaia MK
    Eksp Klin Farmakol; 1994; 57(3):47-50. PubMed ID: 7914121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of the sympathomimetic activity of beta-adrenergic blockaders in the treatment of patients with chronic ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1983; 55(9):35-40. PubMed ID: 6138864
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with preparation LB-46 in various rhythm disorders and ischemic heart disease].
    De La Hoz Fabra J; Pérez Casar F; Carillo Kabana J
    Rev Esp Cardiol; 1970; 23(1):76-99. PubMed ID: 4393269
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of a new beta blocking drug (butidrine) on some biohumoral indices, liver and kidney function and exercise tolerance.
    Barbi G; Tallone B
    Panminerva Med; 1969; 11(7):372-7. PubMed ID: 4390702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.